NSCLC cancer patients treated with Cisplatin-containing chemotherapy.
Measurable disease.
Age of 18 years to 80 years.
You may not be if
Non-small cell lung cancer patients who had undergone radiotherapy or chemotherapy.
Pregnant and lactating females.
History of allergic reactions attributed to compounds of similar chemical or biologic composition to oxaliplatin.
Any other medical or psychiatric condition or severe or chronic laboratory abnormality making the inclusion of the patient in the study inappropriate in the opinion of the investigator.
Clareo Health | Effect of Genetic and Epigenetic Factors on the Clinical Response and Toxicity to Cisplatin Among Egyptian Non-small Cell Lung Cancer Patients
